SynthesisFrontiers in medicine2024

Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials.

Yonghong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.